Choice Plus
Nexus Open Access
Medica Choice
Navigate
Options
Dr. Emily Wang, OD
Dallas, TX
Accepting new patients
Clinical Overview
Dr. Emily Wang, OD works in Dallas, TX as
Explains Conditions Well
Patients said this doctor explains conditions well.
Trustworthy
Patients said this doctor is trustworthy.
Low Wait Times
Patients are usually seen in 10 minutes or less.
Friendly Staff
Patients said the staff was friendly.
Easy Scheduling
Patients said scheduling was easy.
COMPARE OTHER TOP Optometrists
Contrast Dr. Wang with other nearby specialists.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Blue CardBlue Advantage
-
Open ChoiceManaged Choice (Open Access)Premier Care Network Plus - Innovation HealthAetna
Office Locations
-
Dallas Eyeworks7324 Gaston Ave Ste 310, Dallas, TX 75214
-
Optique Inc. - McKinney3636 McKinney Ave Ste 120, Dallas, TX 75204
-
Optix EyeCare & Gallery5330 E Mockingbird Ln Ste 130, Dallas, TX 75206
Patient Experience & Satisfaction
Likelihood to recommend Dr. Wang
5.0
Based on 1 Reviews
5 Stars (1)
4 Stars (0)
3 Stars (0)
2 Stars (0)
1 Star (0)
Leave a review
How likely are you to recommend Dr. Wang?
Patient Reviews
Apr 30, 2025
I’ve had an outstanding experience with Dr. Emily Wang. She is not only highly knowledgeable and thorough in her eye exams, but also incredibly patient and attentive. She took the time to explain everything clearly and made sure all of my concerns were addressed. I felt genuinely cared for throughout the appointment. The entire process—from the exam to selecting lenses—was smooth and stress-free thanks to her professionalism and warm demeanor. I highly recommend Dr. Wang to anyone looking for an optometrist who combines clinical excellence with compassionate care.
Step 1 of 3
Your review of Dr. Emily Wang, OD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Optometry
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Emily Wang, OD accepts new patients on Medical News Today.
Dr. Wang's office is located at 7324 Gaston Ave Ste 310 Dallas, TX 75214. Get a map and directions to Dr. Wang's office here.
Dr. Wang has a star rating of 5.0/5 and has been reviewed 1 times.
Claim Your Profile
Are you Dr. Emily Wang, OD?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A drug candidate created with AI reduced biological age markers across 6 proteomic clocks in a phase 2a trial, suggesting that it may help reverse predicted biological aging.
A recent study has found that elevated NT-proBNP levels could help predict the risk of heart disease in older adults. Experts weigh in on whether the test could eventually have a role in routine cardiovascular risk assessment.
Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the treatment of lung cancer in early trials.
